Composition varies slightly between compounding facilities, but therapeutic formulations typically contain methionine (2550 mg), inositol (50100 mg), choline (50100 mg), and B-complex vitamins (B1, B5, B6, B12) at doses ranging from 15 mg per compound
Proposed Mechanism BPC-157 appears to work through multiple pathways: Maintaining vesicular integrity (affecting VMATs and dopamine transporters) Possibly occupying its own vesicular storage sites Competing for dopamine receptor binding Functionally substituting when dopaminergic neurons are lost This last property, essentially filling in for missing dopamine function, would explain why the peptide counteracts both receptor agonists (apomorphine) and antagonists (haloperidol, fluphenazine, clozapine, sulpiride) with equal effectiveness
Conditions treated by phentermine and Ozempic Is phentermine or Ozempic more effective
Despite extensive animal data suggesting efficacy across depression, anxiety, cognitive decline, and ADHD-relevant models, not a single human clinical trial exists for any mental health application
That is part of how they work